Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Resultsopen access
- Authors
- Kim, Byungwook; Hwang, Sejung; Heo, Eunjeong; Kim, Hyung-sook; Jung, Jongtak; Kim, Eu Suk; Bin Kim, Hong; Lee, Kyunghoon; Park, Jeong Su; Song, Junghan; Lee, Joon Hee; Chung, Jae -Yong; Song, Kyoung-Ho; Yoon, Seonghae
- Issue Date
- Apr-2023
- Publisher
- 대한의학회
- Keywords
- Vancomycin; Therapeutic Drug Monitoring; Acute Kidney Injury; Pharmacokinetics
- Citation
- Journal of Korean Medical Science, v.38, no.14
- Journal Title
- Journal of Korean Medical Science
- Volume
- 38
- Number
- 14
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22534
- DOI
- 10.3346/jkms.2023.38.e101
- ISSN
- 1011-8934
1598-6357
- Abstract
- The current guidelines for therapeutic drug monitoring (TDM) of vancomycin suggest a target 24-hour area under the curve (AUC0-24) of 400 to 600 mg*h/L for serious methicillinresistant Staphylococcus aureus infections. In this study, the predictabilities of acute kidney injury (AKI) of various TDM target parameters, target levels, and sampling methods were evaluated in patients who underwent TDM from January 2020 to December 2020. The AUC0-24 and trough values were calculated by both one- and two-point sampling methods, and were evaluated for the predictability of AKI. Among the AUC0-24 cutoff comparisons, the threshold value of 500 mg*h/L in the two sampling methods was statistically significant (P = 0.042) when evaluated for the predictability of AKI. Analysis by an receiver operating characteristic curve estimated an AUC0-24 cutoff value of 563.45 mg*h/L as a predictor of AKI, and was proposed as the upper limit of TDM target.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.